Grants ReportingThe following table details all grants that Cancer Australia has funded since 1 January 2009.
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Cancer Council Victoria
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A web-based intervention to reduce distress and improve quality of life among younger women with breast cancer: A RCT. App562002. CA-A0809/05
$109,937.18 15/12/2008 53 Carlton 3053
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Towards new screening tests for oesophageal adenocarcinoma Appl ID: 552449
$512,325 01/01/2009 59 Herston QLD 4006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Newcastle
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Targeting p53 isoforms, Δ40p53 and p53β, to promote chemo-sensitivity in human melanoma. App569284. CA-A0809/49
$20,625 04/01/2009 12 Callaghan 2308
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Queensland Health
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Phase II Efficacy Study of Chemo-Radiotherapy in PET Staged II-III Merkel Cell Carcinoma of the Skin. App551200. CA-A0809/06
$101,750 13/01/2009 72 Woolloongabba 4102
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Psychological morbidity, unmet needs, quality of life and patterns of care in migrant cancer patients: The first year. App571009. CA-A0809/37
$20,229.83 14/01/2009 12 Sydney 2006
1 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
The University of Wollongong
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: In vivo assessment of small molecule uPA-directed prodrugs for the treatment of malignant disease. App573432. CA-A0809/09
$20,556.25 14/01/2009 25 Wollongong 2522
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: The role of intraprostatic glucocorticoid action in prostate physiology and pathology. App571311. CA-A0809/10
$20,229.83 14/01/2009 12 Sydney 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Identification of candidate tumour suppressor genes inactivated by promoter methylation in melanoma cell lines. App552466. CA-A0809/25
$20,556.25 20/01/2009 12 Herston 4006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Response to chemotherapy in ovarian cancer. App552481. CA-A0809/22
$625,625 20/01/2009 39 Herston 4006
Cancer Australia
Support for Cancer Clinical Trials Program and Boost Cancer Research Program
Primary Care Collaborative Clinical trials Group (PC4TG) through University of Western Australia
Support for Cancer Clinical Trials Program - CA-A0910/16
$311,230.70 27/01/2009 17 University of WA, WA 6009
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Macquarie University
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Evaluation of an online decision aid for women with breast cancer considering reconstructive surgery. App543400. CA-A0809/29
$103,803.34 30/01/2009 60 North Ryde 2109
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: The Renin Angiotensin System – a Novel Target in the Treatment of Colorectal
$20,363.20 30/01/2009 18 Parkville 3010
2 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Liver Metastases. App566536. CA-A0809/47
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Overcoming chemo-resistance in leukaemia: application of Vorinostat and ABT-737 to a new in vivo model of CLL. App566746. CA-A0809/46
$20,350 30/01/2009 12 Parkville 3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Characterisation of the kConFab BRCAX cohort for selected breast cancer susceptibility loci and effect on cancer risk. App566791. CA-A0809/44
$527,107.90 30/01/2009 71 Parkville 3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A randomised trial of stereotactic vs conventional radiotherapy for inoperable early stage non-small cell lung cancer. App566813. CA-A0809/45
$286,000 30/01/2009 59 Parkville 3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Methylation in ductal carcinoma in situ. App566882. CA-A0809/43
$294,398.69 30/01/2009 48 Parkville 3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Characterisation of a tumour-associated PIK3CA mutation using a novel mouse model. App566974. CA-A0809/42
$20,625 30/01/2009 12 Parkville 3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Reversing the debilitating effects of radiotherapy-induced damage in juvenile brain. App566976. CA-A0809/41
$20,625 30/01/2009 12 Parkville 3010
Cancer Australia
Support for Cancer Clinical Trials Program
Australian and New Zealand Children’s
Support for Cancer Clinical Trials Program - CA-A00809/19
$770,880.00 30/01/2009 18 Parkville 3052
3 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Haematology/Oncology Group (ANZCHOG)
Cancer Australia
Support for Cancer Clinical Trials Program
Australasian Sarcoma Study Group (ASSG) through University of Melbourne
Support for Cancer Clinical Trials Program - CA-A0809/18
$760,839.20 30/01/2009 18 University of Melbourne, VIC 3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Garvan Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: DNA methylation alterations as detection markers for early ovarian cancer. App535957. CA-A0809/28
$639,375 02/02/2009 36 Darlinghurst 2010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of NSW
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Role of Heat Shock Proteins in the Stromal Reaction of Pancreatic Cancer. App568851. CA-A0809/27
$20,350 02/02/2009 12 Sydney 2052
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Melbourne Health
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Resveratrol in the chemoprevention of colorectal neoplasia. App544307. CA-A0809/39
$633,325 03/02/2009 60 Parkville 3050
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A nurse led psychosocial intervention with peer support to reduce psychosocial needs in women with gynaecological cancer. App566942. CA-A0809/40
$127,930 03/02/2009 24 Parkville 3010
Cancer Australia
Support for Cancer Clinical Trials Program
Cooperative Trials Group for Neuro-Oncology (COGNO) through University of Sydney
Support for Cancer Clinical Trials Program - CA-A0809/17
$364,455.30 03/02/2009 17 University of Sydney, NSW 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Prince Charles Hospital
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Individualising treatment for mesothelioma. App550600. CA-A0809/48
$384,450 04/02/2009 50 Chermside 4032
Cancer Priority Driven University of Priority Driven Collaborative $285,360.90 04/02/2009 52 Callaghan 23084 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
AustraliaCollaborative Cancer Research Scheme
Newcastle
Cancer Research Scheme (PDCCRS) 2008: Blood cancer survivors and support persons: A national survey of rural/urban unmet needs and psychological disturbance. App569290. CA-A0809/50
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Incidence and risk factors for lymphoedema secondary to breast cancer: a prospective cohort study. App570801. CA-A0809/30
$581,916.25 04/02/2009 48 Sydney 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Quality of life outcomes and cost effectiveness of pelvic exenteration for people with advanced rectal cancer. App570860. CA-A0809/31
$211,777.50 04/02/2009 71 Sydney 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Phase III study in patients with Locally Advanced Pancreatic cancer: Gemcitabine +/- chemoradiotherapy & +/- erlotinib. App570948. CA-A0809/34
$284,900 04/02/2009 90 Sydney 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Genome-wide analysis of pre-mRNA splicing regulation by RBM4. App570874. CA-A0809/32
$20,597.50 05/02/2009 12 Sydney 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Understanding the psychosocial sequelae of surviving testicular cancer. App570961. CA-A0809/35
$104,940 05/02/2009 24 Sydney 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Short Course Oncology Therapy - A Study of Adjuvant
$329,752.50 05/02/2009 59 Sydney 2006
5 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Chemotherapy in Colorectal Cancer by the CACTUS and OCTO Groups. App571314. CA-A0809/38
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: The role of melanoma stem cells in melanomagenesis. App570778. CA-A0809/21
$20,625 09/02/2009 12 Sydney 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Southern Queensland
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A Randomized Trial of a Shorter Radiation Fractionation Schedule for the Treatment of Localized Prostate Cancer (PROFIT – Prostate Fractionated Irradiation Trial). App570403. CA-A0809/20
$487,850 12/02/2009 36 Toowoomba 4350
Cancer Australia
Support for Cancer Clinical Trials Program
Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) through University of Sydney
Support for Cancer Clinical Trials Program - CA-A0809/52
$839,905.00 18/02/2009 18 University of Sydney, NSW 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Walter and Eliza Hall Institute
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Role of the GATA-3 transcription factor as a tumour suppressor and potential therapeutic target in breast cancer. App575572. CA-A0809/53
$326,803.95 20/02/2009 36 Parkville 3050
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Adelaide
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Faecal microflora and circulating proinflammatory cytokines: key elements to chemotherapy-induced diarrhoea. App553601. CA-A0809/54
$20,625 25/02/2009 12 Adelaide 5005
Cancer Australia
Improved Cancer Control
Improved Cancer Control
Cancer Institute NSW
The continuation of Cancer Service Networks National Demonstration Program (CanNET) in New South Wales
$932,091.60 16/03/2009 56 Alexandria, NSW 1435
6 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of NSW
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Development of an optimised multidisciplinary intervention for post-cancer fatigue. App568828. CA-A0809/64
$474,650 15/06/2009 61 Sydney 2052
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Adelaide
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: A combinatorial approach targeting androgen signalling for treatment of prostate cancer. App627229. CA-A0910/87
$321,028.95 01/01/2010 36 Adelaide 5005
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of South Australia
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Development of microfluidic chips to isolate and analyse peripheral blood cell populations in pancreatic cancer patients. App631921. CA-A0910/56
$24,750 06/01/2010 12 Adelaide 5001
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Ludwig Institute of Cancer Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Mechanisms of abiraterone resistance in prostate cancer. App603107. CA-A0910/57
$216,150 18/01/2010 36 Heidelberg 3084
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Garvan Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Identifying and targeting Docetaxel resistance in hormone refractory prostate cancer. App596858. CA-A0910/54
$213,950 20/01/2010 36 Darlinghurst 2010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Monash University
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: The role of the EphA3 receptor in the stromal microenvironment of tumours. App606719. CA-A0910/58
$24,750 20/01/2010 12 Clayton 3168
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Monash University Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Novel monoclonal antibodies for the diagnosis and treatment of epithelial cancers and
$94,806.80 21/01/2010 12 Clayton 3168
7 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
cancer stem cells. App606552. CA-A0910/55
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Queensland
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: LACE – Laparoscopic Approach to Carcinoma of the Endometrium. An International Multicentre Randomised Phase 3 Clinical Trial. App631523. CA-A0910/46
$643,775 27/01/2010 36 Brisbane 4072
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Lymphocyte receptors that regulate tumor development and therapy. App628304. CA-A0910/49
$24,571.80 29/01/2010 12 Parkville 3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Preventing Breast Cancer in BRCA1 and BRCA2 Mutation Carriers: kConFab Follow-Up Project. App628333. CA-A0910/51
$327,731.25 29/01/2010 36 Parkville 3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Identification of BRCAx Genes through targeted next generation sequencing. App628610. CA-A0910/52
$231,000 29/01/2010 36 Parkville 3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Ludwig Institute of Cancer Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: IL-11: A preclinical target for inflammation-associated gastrointestinal cancer. App603121. CA-A0910/45
$24,750 01/02/2010 12 Heidelberg 3084
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of New South Wales
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Too much, too soon? The impact of treatment-focused genetic testing in patients newly diagnosed with breast cancer. App630405. CA-A0910/62
$217,998 09/02/2010 42 Sydney 2052
Cancer Australia
Priority Driven Collaborative
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme $24,181.58 12/02/2010 12 Parkville 3010
8 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Cancer Research Scheme
(PDCCRS) 2009: Characterization of the immunoregulatory capacity of antibody-based immunotherapeutics in established cancer. App628338. CA-A0910/48
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Curtin University of Technology
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Examination of surgical margins with a positron emission tomography (PET) probe in DCIS and invasive breast cancer. App594409. CA-A0910/64
$41,937.50 17/02/2010 24 Perth 6845
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Trans Tasman Radiation Oncology Group Limited
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Phase II Trial of Integrated Preoperative RT/Chemo with Oxaliplatin, 5-FU and FA in Locally Advanced Rectal Cancer. App626200. CA-A0910/65
$118,250 23/02/2010 40 Waratah 2298
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Newcastle
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Altered nucleotide excision repair in melanoma in response to cisplatin and UV-light irradiation. App631019. CA-A0910/63
$24,750 24/02/2010 15 Callaghan 2308
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: The role of microRNAs in the progression of ductal carcinoma in situ to invasive breast cancer. App632547. CA-A0910/69
$24,750 24/02/2010 12 Sydney 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Timing of surgery and adjuvant chemotherapy for hepatic metastases from colorectal cancer. App632737. CA-A0910/73
$660,000 24/02/2010 53 Sydney 2006
Cancer Australia
Priority Driven Collaborative
University of Sydney
Priority Driven Collaborative Cancer Research Scheme $209,481.80 24/02/2010 39 Sydney 2006
9 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Cancer Research Scheme
(PDCCRS) 2009: Phase 2 study of aromatase inhibitors in women with potentially hormone sensitive recurrent/metastatic gynaecological neoplasms: PARAGON. App632740. CA-A0910/75
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: hOGG1 in human skin carcinogenesis. App632760. CA-A0910/74
$23,443.75 24/02/2010 12 Sydney 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Randomised trial of consumer-led familial cancer risk tool & GP triage on risk-appropriate colorectal cancer screening. App632887. CA-A0910/70
$537,901.37 24/02/2010 46 Sydney 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Telomere trimming: a novel mechanism for preventing unlimited cellular proliferation. App633214. CA-A0910/72
$23,443.75 24/02/2010 12 Sydney 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Queensland
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Post-operative enteral nutrition in patients with advanced epithelial ovarian cancer. App631524. CA-A0910/77
$261,910 25/02/2010 36 Brisbane 4072
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Monash University
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Pilot of a population-based prostate cancer clinical registry. App606927. CA-A0910/80
$217,387.50 26/02/2010 36 Clayton 3168
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Newcastle
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Control of malignant glioma by naturally occurring oncolytic enteroviruses. App631059. CA-A0910/68
$23,426.70 02/03/2010 12 Callaghan 2308
10 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
CSIRO
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: The effects of microencapsulated butyrylated high amylose maize starch and fish oil on colorectal cancer risk in rats. App593504. CA-A0910/88
$23,153.63 19/03/2010 12 Adelaide 5000
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: A randomised controlled trial evaluating a nurse-led survivorship care package (SurvivorCare) for bowel cancer survivors. App628581. CA-A0910/86
$206,250 29/03/2010 48 Parkville 3010
Cancer Australia
Support for Cancer Clinical Trials Program and Boost Cancer Research Program
Primary Care Collaborative Clinical trials Group (PC4TG) through University of Western Australia
Support for Cancer Clinical Trials Program - CA-A0910/126
$1,506,347.70 22/06/2010 36 University of WA, WA 6009
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Trans-Tasman Radiation Oncology Group Limited (TROG)
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: A randomised comparison of anastrozole commenced before and continued during adjuvant radiotherapy for breast cancer versus anastrozole and subsequent anti-oestrogen therapy delayed until after radiotherapy ApplID: 626201
$660,000 25/06/2010 48 Newcastle, NSW 2310
Cancer Australia
Support for Cancer Clinical Trials Program
Australasian Gastro-Intestinal Trials Group (AGITG) through University of Sydney
Support for Cancer Clinical Trials Program - CA-A0910/123
$1,541,030.40 25/06/2010 36 University of Sydney,
NSW 2006
Cancer Australia
Support for Cancer Clinical Trials Program
Australasian Leukaemia and Lymphoma Group (ALLG)
Support for Cancer Clinical Trials Program - CA-A0910/131
$1,549,296.10 25/06/2010 36 East Melbourne, 3002
Cancer Australia
Support for Cancer Clinical Trials Program
Australasian Lung Cancer Trials Group (ALTG) through University of
Support for Cancer Clinical Trials Program - CA-A0910/121
$1,523,481.30
25/06/2010 36 University of Sydney, NSW
2006
11 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Sydney
Cancer Australia
Support for Cancer Clinical Trials Program
Australia and New Zealand Breast Cancer Trials Group (ANZBCTG)
Support for Cancer Clinical Trials Program - CA-A0910/127
$1,541,639.00 25/06/2010 36 Waratah, NSW 2298
Cancer Australia
Support for Cancer Clinical Trials Program
Australian and New Zealand Children’s Haematology/Oncology Group (ANZCHOG)
Support for Cancer Clinical Trials Program - CA-A0910/129
$1,547,700.00 25/06/2010 36 Royal Melbourne
Hospital, VIC 3050
Cancer Australia
Support for Cancer Clinical Trials Program
Australia New Zealand Gynaecological Oncology Group (ANZGOG) through University of Sydney
Support for Cancer Clinical Trials Program - CA-A0910/122
$1,531,997.50 25/06/2010 36 University of Sydney,
NSW 2006
Cancer Australia
Support for Cancer Clinical Trials Program
Australia and New Zealand Melanoma Trials Group (ANZMTG) through University of Sydney
Support for Cancer Clinical Trials Program - CA-A0910/119
$1,534,589.43 25/06/2010 36 University of Sydney,
NSW 2006
Cancer Australia
Support for Cancer Clinical Trials Program
Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) through University of Sydney
Support for Cancer Clinical Trials Program - CA-A0910/124
$1,534,308.60 25/06/2010 36 University of Sydney,
NSW 2006
Cancer Australia
Support for Cancer Clinical Trials Program
Australasian Sarcoma Study Group (ASSG) through University of Melbourne
Support for Cancer Clinical Trials Program - CA-A0910/128
$1,536,150.00 25/06/2010 36 University of
Melbourne, VIC 3010
Cancer Australia
Support for Cancer Clinical Trials Program
Cooperative Trials Group for Neuro-Oncology (COGNO) through University of Sydney
Support for Cancer Clinical Trials Program - CA-A0910/120
$1,242,144.20 25/06/2010 36 University of Sydney,
NSW 2006
Cancer Australia
Support for Cancer Clinical Trials Program
Psycho-oncology Co-operative Research Group (PoCoG) through University of
Support for Cancer Clinical Trials Program - CA-A0910/132
$1,627,835.00
25/06/2010 36 University of Sydney, NSW
2006
12 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Sydney
Cancer Australia
Support for Cancer Clinical Trials Program
TransTasman Radiation Oncology Group (TROG)
Support for Cancer Clinical Trials Program -CA-A0910/125
$1,549,297.20 25/06/2010 36 Waratah, NSW 2287
Cancer Australia
Improved Cancer Control
Improved Cancer Control
Anti - Cancer Foundation of South Australia
Continuing Implementation of the National Cancer Data Strategy
$34,402.50 01/01/2011 3 Eastwood SA 5063
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
2010 PdCCRS: microRNA miR-211 as a novel tumour suppressor for melanoma. App1011300
$49,500.00 21/01/2011 20 Herston QLD 4006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
2010 PdCCRS: Development of a model to classify mismatch repair gene sequence variants of uncertain clinical significance. App1010859
$660,000.00 21/01/2011 48 Herston QLD 4006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Griffith University
2010 PdCCRS: ProsCan for Life: A Multimodal Supportive Care Intervention for Men with Prostate Cancer. App1008320
$329,006.70 24/01/2011 36 Nathan QLD 4111
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Cancer Council QLD
2010 PdCCRS - A multi-level investigation of inequalities in clinical and psychosocial outcomes for women after breast cancer. App1006339
$647,619.50 02/02/2011 36 Fortitude Valley, QLD 4006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
The University of Western Australia
2010 PdCCRS: Endocrine therapies for early breast cancer: health outcomes and policy implications in Australian clinical practice. Targets the National Health Priority Area of Cancer Control, specifically focussing on breast cancer treatment in Australian women. App1011488
$171,048.90 04/02/2011 49 Crawley WA 6009
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
2010 PdCCRS: Identifying markers of risk and outcome in ovarian and breast cancer via efficient of DNA methylation in peripheral blood. App1011143
$191,213.00 08/02/2011 46 Herston QLD 4006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2010 PdCCRS: Genetic and environmental factors in invasive cervical cancer: a twin study. App1008811
$429,458.70 09/02/2011 36 Parkville VIC 3010
13 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2010 PdCCRS: Fulfilling the vision of youth-friendly cancer care: How well are we meeting the psychosocial needs of AYA patients? App1010977
$164,776.70 09/02/2011 42 Parkville VIC 3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Originally University of Melbourne now Ludwig Institute of Cancer Research
2010 PdCCRS: Identifying therapeutic targets by profiling DNA repair in lung cancer CA-A1011/18. App1009892
$552,776.40 09/02/2011 46 Heidelberg VIC 3084
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2010 PdCCRS: Personalised breast cancer risk prediction in BRCA mutation carriers. App1007765
$152,780.10 09/02/2011 63 Parkville VIC 3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2010 PdCCRS: Identification of Men with a genetic predisposition to Prostate Cancer: targeted screening in BRCA1/2 mutation carriers and controls - The Impact study. App1006349
$465,329.70 09/02/2011 40 Parkville VIC 3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2010: A phase III randomised trial of postmastectomy chest wall irradiation in intermediate risk operable breast cancer. App1004707. CA-A1011/15
$561,000 09/02/2011 36 Parkville 3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
The Australian National University
2010 PdCCRS: Targeting of two Aspects of Metabolism (TOTAM) for cancer therapy. App1008861
$546,165.40 14/02/2011 36 Canberra ACT 200
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of New South Wales
2010 PdCCRS: Identification of anti-apoptotic signalling pathways in malignant gliomas. App1010484
$49,500.00 15/02/2011 12 Sydney NSW 2052
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of New South Wales
2010 PdCCRS: Role of dietary compounds on PGC-1 alpha methylation in colorectal cancer. App1010361
- 15/02/2011 36 Sydney NSW 2052
Cancer Australia
Priority-driven Collaborative Cancer Research
University of New South Wales
2010 PdCCRS: Targeting drug resistant genes in brain cancer: delivery of siRNA to improve cancer therapy.
$49,500.00 15/02/2011 19 Sydney NSW 2052
14 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Scheme App1003650
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Queensland
Autofluorescence imaging for early detection and surgical margin delineation of oral cancers and pre-cancers. App1009996
$558,131.20 21/02/2011 44 St Lucia, QLD 4072
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Adelaide
The role of CD123 in MDSA and AML. App1010336 $316,276.40 24/02/2011 36 North Terrace, SA 5005
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2010 PdCCRS: Whole Brain Radiotherapy following local treatment of intracranial metastases of melanoma - a randomised phase III trial. App1009485
$650,111.00 01/03/2011 60 Sydney, NSW 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2010 PdCCRS: A randomised, placebo-controlled trial of concurrent cediranib [AZD2171] with platinum - based chemotherapy & maintenance cediranib in women with platinum sensitive relapsed ovarian cancer: ICON 6. App1006602
$270,597.80 01/03/2011 24 Sydney, NSW 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2010 PdCCRS: Tumour protein D52 over-expression and DNA repair in cancer. App1007020
$48,132.40 01/03/2011 12 Sydney, NSW 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2010 PdCCRS: START Phase III Study of Active Surveillance Therapy Against Radical Treatment in Patients Diagnosed with Favourable Risk Prostate Cancer. App1004932
$329,320.20 01/03/2011 38 Sydney, NSW 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Curtin University of Technology
2010 PdCCRS: Meeting the education and support needs of women with breast cancer who are referred for radiotherapy: A multiple - baseline study. App1006458
$220,993.30 01/03/2011 59 Perth, WA 6845
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Adelaide
2010 PdCCRS: A novel approach to predict metastatic potential of prostate cancer at diagnosis. App1012337
$650,905.20 01/03/2011 36 Adelaide, SA 5005
Cancer Priority-driven University of 2010 PdCCRS: The impact of $48,129.40 01/03/2011 12 Sydney, NSW 200615 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
AustraliaCollaborative Cancer Research Scheme
Sydney
aberrant progesterone signalling on lineage specification during early malignant transformation. App1009094
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2010 PdCCRS: Alternative lengthening of Telomeres (ALT) in lung cancer: analysis of effects on patient outcomes and development of a blood test. App1012032
$48,981.90 01/03/2011 12 Sydney, NSW 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2010 PdCCRS: NITRO - A randomised, phase 3 trial of adding nitro-glycerine to first line chemotherapy for advanced non - small cell lung cancer. App1006315
$656,421.70 01/03/2011 36 Sydney, NSW 2006
Cancer Australia
Improved Cancer Control
Improved Cancer Control
Cancer Institute NSW
Maintaining the eviQ Primary Health Care modules $119,900.00 01/03/2011 16
Australian Technology Park,
NSW2015
Cancer Australia
Improved Cancer Control
Improved Cancer Control
The Australian Lung Foundation
Travel grants for lung cancer nurses to attend the International Lung Cancer Conference in Amsterdam
$22,800.00 29/03/2011 6 Bowen Hills, QLD 4006
Cancer Australia
Improved Cancer Control
Improved Cancer Control
Queensland Health
Cancer care coordination for Indigenous people residing in Far North Queensland
$438,743.80 25/05/2011 18 Brisbane, QLD 4000
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Monash University
2010 PdCCRS: Determining the causes of observed variation in survival after diagnosis of prostate cancer. App1010384
$627,607.20 30/05/2011 36 Clayton, VIC 3800
Cancer Australia
Improved Cancer Control
Improved Cancer Control
Clinical Oncology Society of Australia
Building Cancer Support Networks Initiative - Better Cancer Support through Consumers (BCSN)
$2,970,000.00 02/06/2011 12 Sydney. NSW 2010
Cancer Australia Data Improved
Cancer ControlWomen's and Children's Hospital
For the provision of Pilot Testing of a Data Set Specifications (DSS) for Adolescents and Young Adults with Cancer
$16,648.50 24/06/2011 5 North Adelaide, SA 5006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
Sequencing the ovarian cancer genome: molecular determinants of tumour growth & treatment failure. App1004673
$660,000.00 30/06/2011 36 Parkville, VIC 3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland University of Technology
Skin cancer prevention & early detection for Generation Y. App1011999
$343,776.40 30/06/2011 36 Brisbane, QLD 4001
16 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Cancer Australia Data Improved
Cancer Control Austin Health
Pilot project will obtain information on feasibility of data collection of the DSS items and the rate of data-item completion during the pilot project period.
$35,255.54 30/06/2011 6 Heidelberg VIC 3084
Cancer Australia Data Improved
Cancer ControlPrince Charles Hospital
Pilot project will obtain information on feasibility of data collection of the DSS items and the rate of data-item completion during the pilot project period.
$18,820.20 30/06/2011 6 Chermside, QLD 4032
Cancer Australia Data Improved
Cancer Control
Royal Hobart Hospital (Department of Health and Human Services)
Pilot project will obtain information on feasibility of data collection of the DSS items and the rate of data-item completion during the pilot project period.
$12,425.24 30/06/2011 6 Hobart, TAS 7000
Cancer Australia Data Improved
Cancer Control Nepean Hospital
Pilot project will obtain information on feasibility of data collection of the DSS items and the rate of data-item completion during the pilot project period.
$27,056.13 30/06/2011 6 Penrith, NSW 2751
Cancer Australia Data Improved
Cancer ControlPeter MacCallum Cancer Centre
For the provision of Pilot Testing of a Data Set Specifications (DSS) for Adolescents and Young Adults with Cancer
$36,960.00 30/06/2011 5 A'Beckett Street, VIC 8006
Cancer Australia Data Improved
Cancer ControlSouth Eastern Sydney Local Health District
Pilot project will obtain information on feasibility of data collection of the DSS items and the rate of data-item completion during the pilot project period.
$16,376.80 27/07/2011 4 Randwick, NSW 2031
Cancer Australia
Improved Cancer Control
Improved Cancer Control
Breast Cancer Network Australia
For the provision of projects that aim to strengthen support for women with breast cancer
$1,366,200.00 04/11/2011 31 Camberwell, VIC 3124
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2011 PdCCRS – The role of adjuvant chemotherapy in high-risk endometrial cancer. App1027151
$330,965.80 09/01/2012 47 Sydney, NSW 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2011 PdCCRS – Phase III trial of Concurrent and Adjuvant Temozolomide chemotherapy in non-1p/19q non deleted anaplastic glioma - The CATNON Intergroup Trial.
$217,896.25 09/01/2012 36 Sydney, NSW 2006
17 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
App1026842
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2011 PdCCRS - Evaluation of a web-based tool for estimating and explaining prognosis in advanced cancer. App1032121
$139,933.75 09/01/2012 48 Sydney, NSW 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2011 PdCCRS - Evaluation of a psychological and educational intervention for fear of cancer recurrence; A cluster randomised controlled trial. App1022584
$182,124.07 09/01/2012 64 Sydney, NSW 2006
Cancer Australia
Improved Cancer Control
Improved Cancer Control
Breast Cancer Network Australia Hope and Hurdles Pack $165,000.00 01/02/2012 5 Camberwell, VIC 3124
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Ludwig Institute for Cancer Research
2011 PdCCRS - Discovery of colorectal cancer subtype associated tumour suppressor genes using next-generation sequencing and high throughput functional genomics. App1030098
$482,476.50 02/02/2012 36 Heidelberg, VIC 3084
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Edith Cowan University
2011 PdCCRS - Can exercise ameliorate treatment toxicity during the initial phase of testosterone suppression in prostate patients? Is this more effective than delayed rehabilitation and what is the time course and persistence of benefits? App1029901
$163,634.45 02/02/2012 46 Joondalup, WA 6027
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of New South Wales
2011 - PdCCRS 'ReCaPTure LiFe': A phase 11 randomised trial of a psychological intervention to support adolescent and young adult cancer survivors. App1022868
$148,811.45 17/02/2012 36 Sydney, NSW 2052
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Garvan Institute of Medical Research
2011 - PdCCRS - The role of p53-regulated microRNAs in epithelial to mesenchymal transition, and their potential as therapeutic targets against metastatic breast cancer. App1034561
$24,750.00 17/02/2012 12 Sydney. NSW 2010
Cancer Australia
Priority-driven Collaborative Cancer Research
Menzies Research Institute
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Integrative genomic approaches to
$567,270 17/02/2012 68 Hobart, TAS 7000
18 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Schemeunderstanding the genetics of prostate cancer. App ID: 544938; Ref: CA-A0809/11
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Wollongong
2011 - PdCCRS -Quantifying the impact of imaging choice for breast cancer radiotherapy. App1033237
$143,585.20 21/02/2012 41 Wollongong, NSW 2522
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
The State of Queensland through Queensland Health via The Princess Alexandra Hospital Metro South District
2011 - PdCCRS - A randomised Phase III trial of High Dose Palliative Radiotherapy (HDPRT) versus concurrent Chemotherapy and HDPRT (C-HDPRT) in patients with Good performance Status. Locally Advanced/Small Volume Metastatic Non-small Cell Lung Cancer not suitable for Radical Chemo-therapy. App1030265
$327,214.80 21/02/2012 72 Woolloongabba, QLD 4102
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Western Australia
2011 - PdCCRS - The initiation of the cellular immune response to cutaneous melanoma. App1034730
$24,750.00 21/02/2012 12 Heidelberg, VIC 3084
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2011 - PdCCRS - Inhibition of Glioblastoma Invasion by Novel Dynamin Ring Stabilisers. App1021331
$24,399.38 21/02/2012 12 Sydney, NSW 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2011 - PdCCRS - Mechanism of 133p53 isoform oncogenicity. App1030408
$24,399.38 21/02/2012 12 Sydney, NSW 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2011 - PdCCRS - Ginkgo biloba preserves cognitive function in women treated with adjuvant chemotherapy for early breast cancer: a double-blind, placebo-controlled, randomised phase III trial. App1029819
$220,000.00 21/02/2012 71 Sydney, NSW 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2011 - PdCCRS - The role of Single Stranded DNA Binding Proteins in the Alternative Lengthening of Telomeres mechanism. App1030040
$48,798.75 21/02/2012 24 Sydney, NSW 2006
Cancer Australia
Priority-driven Collaborative
University of Sydney
2011 - PdCCRS - The use of RNAi to identify new $411,650.80 21/02/2012 36 Sydney, NSW 2006
19 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Cancer Research Scheme
therapeutic targets for malignant mesothelioma. App1031821
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2011 PdCCRS - Targeting dormancy in metastatic breast cancer. App1020272
$148,179.90 23/02/2012 36 Melbourne, VIC 3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2011 PdCCRS - Defining the hereditary contribution to ovarian cancer: The role of mismatch repair genes. App1024096
$614,090.40 23/02/2012 41 Melbourne, VIC 3010
Cancer Australia
Improved Cancer Control
Improved Cancer Control
Breast Cancer Network Australia My Journey Kit $248,600.00 23/02/2012 6 Camberwell, VIC 3124
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of New South Wales
2011 - PdCCRS - Thromboembolism in Cancer. App1026790
$24,750.00 20/03/2012 20 Sydney, NSW 2052
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2011 - PdCCRS - Determining Predictors of Sensitivity to Chk Inhibitors in Metastatic Melanoma. App1029585
$651,585.00 20/03/2012 46 Melbourne , VIC 3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
2011 - PdCCRS - Salinomycin a potential glioma stem cell targeting therapy. App1031303
$240,862.50 20/03/2012 12 Brisbane, QLD 4006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Adelaide
2011 - PdCCRS - Androgen receptor action in the prostate cancer microenvironment. App1032970
$316,571.20 20/03/2012 43 Adelaide, SA 5005
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Adelaide
2011 - PdCCRS - Reactivating the p53 pathway as a novel therapeutic approach to cancer treatment. App1034715
$49,500.00 20/03/2012 24 Adelaide, SA 5005
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Adelaide
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2011 - A novel method to detect and characterise dysplasia and early cancer in Barrett's oesophagus. Appl ID: 1031971
$24,750 20/03/2012 24 Adelaide, SA 5005
Cancer Australia
Priority-driven Collaborative
University of Adelaide
Priority Driven Collaborative Cancer Research Scheme $290,766.30 20/03/2012 48 Adelaide, SA 5005
20 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Cancer Research Scheme
(PDCCRS) 2011: Is elevated N-cadherin expression a poor prognostic indicator in multiple myeloma patients. Appl ID: 1030518
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Newcastle
2011 - PdCCRS - The therapeutic potential of targeting S100A2 calcium-binding protein in pancreatic cancer. App1033781
$44,362.50 03/04/2012 27 Callaghan, NSW 2308
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
Cancer Council South Australia
Supporting people with Cancer grant initiative $85,800.00 12/06/2012 24 Eastwood, SA 5063
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
The Prince Charles Hospital
Supporting people with Cancer grant initiative $88,000.00 12/06/2012 30 Brisbane, QLD 4032
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
Paediatric Integrated Cancer Service
Supporting people with Cancer grant initiative. CA-A1112/42
$86,361.00 12/06/2012 25 Parkville, VIC 3056
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
Australian Lung Foundation
Supporting people with Cancer grant initiative $83,050.00 12/06/2012 24 Bowen Hills, QLD 4006
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control BreaCan Supporting people with
Cancer grant initiative $88,000.00 12/06/2012 24 Melbourne, VIC 3000
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
Cancer Council VIC
Supporting people with Cancer grant initiative $86,460.00 12/06/2012 24 Carlton, VIC 3053
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control CanRevive Supporting people with
Cancer grant initiative $87,934.00 25/06/2012 24 Sydney, NSW 2000
Cancer Australia
Improved Cancer Control
Improved Cancer Control
The Medical Oncology Group of Australia
To support the attendance at the ACORD Workshop of four (4) early career oncology clinical researchers from Australia selected as participants and the attendance as a faculty member of the Cancer Australia Chair in Quality of Life Research.
$24,750.00 26/06/2012 1 Sydney, NSW 2000
Cancer Australia
Supporting People with Cancer Grant
Improved Cancer Control
Cancer Voices Victoria
Supporting people with Cancer grant initiative
$84,392.00 27/06/2012 24 Carlton, VIC 3053
21 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
initiative
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
Australian Cancer Survivorship
Supporting people with Cancer grant initiative $88,000.00 28/06/2012 25 East Melbourne, VIC 3002
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
Cancer Council NSW
Supporting people with Cancer grant initiative $88,000.00 28/06/2012 25 Woolloomooloo, NSW 2011
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
University of South Australia
Supporting people with Cancer grant initiative $82,500.00 28/06/2012 24 Adelaide, SA 5000
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
Menzies School of Health and Research
Supporting people with Cancer grant initiative $87,774.00 29/06/2012 24 Spring Hill, QLD 4000
Cancer Australia
Supporting People with Cancer Grant initiative
Improved Cancer Control
Cancer Council TAS
Supporting people with Cancer grant initiative $16,702.40 29/06/2012 24 Hobart, TAS 7000
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
Wellington Aboriginal Corporation
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$2,260 03/10/2012 3 Wellington, NSW 2820
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
Top End Remote Health Branch
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$2,500 03/10/2012 3 Winnellie, NT 822
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
South Coast Medical Service Aboriginal Corporation
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$2,490 03/10/2012 3 Nowra, NSW 2541
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant
Improved Cancer Control
Napranum Primary Health Care Clinic
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in
$1,850 03/10/2012 3 Wiepa, QLD 4874
22 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Initiative Aboriginal and Torres Strait Islander communities
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
Kalwun Development Corporation Limited
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$2,500 03/10/2012 3 Miami, QLD 4220
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
Inala Community Health Centre
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$1,600 03/10/2012 3 Inala, QLD 4077
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
Illawarra Womens Health Centre
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$2,500 03/10/2012 3 Warilla, NSW 2528
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
Goulburn Valley Health
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$2,600 03/10/2012 3 Wodonga, VIC 3689
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
Western NSW Local Health District, Dubbo Community Health Centre
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$4,000 03/10/2012 3 Dubbo, NSW 2830
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
Dareton Primary Health Centre
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$1,500 03/10/2012 3 Dareton, NSW 2717
Cancer Aboriginal and Improved Bulgarr Ngaru For funding recipients to $4,000 03/10/2012 3 Grafton, NSW 125623 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Australia
Torres Strait Islander Well Women’s Workshop Grant Initiative
Cancer Control Medical Aboriginal Corporation
implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
Cancer Australia
Aboriginal and Torres Strait Islander Registered Training Organisation Grants
Indigenous Wellbeing Centre Ltd
To conduct unit of competency and provide information and support to women with breast cancer for Aboriginal and/or Torres Strait Islander Health Workers.
$11,000 26/10/2012 7.5 Bundaberg QLD 4670
Cancer Australia
Aboriginal and Torres Strait Islander Registered Training Organisation Grants
QLD Aboriginal and Torres Strait Islander Health Worker Education Program Aboriginal Corporation
To conduct unit of competency and provide information and support to women with breast cancer for Aboriginal and/or Torres Strait Islander Health Workers.
$11,000 26/10/2012 7.5 Cairns, QLD 4870
Cancer Australia
Aboriginal and Torres Strait Islander Registered Training Organisation Grants
Central Australian Remote Health Development Services Ltd
To conduct unit of competency and provide information and support to women with breast cancer for Aboriginal and/or Torres Strait Islander Health Workers
$11,000 28/11/2012 7 Alice Springs 870
Cancer Australia
Aboriginal and Torres Strait Islander Registered Training Organisation Grants
Kimberley Aboriginal Medical Services Council Inc
To conduct unit of competency and provide information and support to women with breast cancer for Aboriginal and/or Torres Strait Islander Health Workers.
$11,000 28/11/2012 6 Broome 6725
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Cancer Council Queensland
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Improving the Psychosocial Health of People with Cancer and their Carers: A Community-Based Approach. App561701. CA-A0809/07
$297,156.20 13/01/2013 47 Fortitude Valley 4006
Cancer Australia
Ralph Lauren Pink Pony 12-13
Ralph Lauren Pink Pony Campaign Scholarships $17,500 14/02/2013 10 Various Various
Cancer Australia
Improved Cancer Control
Southern Adelaide Local Area Health Network: Repatriation General Hospital
Prostate Cancer Data Set Specification Pilot Project $19,121.81 25/02/2013 5 Daws Park 5041
24 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Improved Cancer Control
Murrumbidgee Medicare Local
For funding recipients to implement and run a Well Women’s Workshop to promote and encourage breast awareness and early detection of breast cancer in Aboriginal and Torres Strait Islander communities
$2,800 28/02/2013 5 Tumut, NSW 2720
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: High Risk genes for Lobular Breast Cancer. Appl ID 1047347.
$100,000 01/03/2013 36 Parkville 3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Technology Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Molecular characterisation of a novel target in multiple myeloma. Appl ID 1050067.
$23,745.25 01/03/2013 15 Broadway 2007
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
The Australian National University
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Equivalence of sun exposure and vitamin D supplementation in vitamin D insufficiency. Appl ID 1045198
$582,911 01/03/2013 58 Acton 200
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Walter and Eliza Hall Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Innate immune cell protection and colon cancer. Appl ID 1050241
$26,826.53 01/03/2013 12 Parkville 3052
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: PETACC-6: Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer. Appl ID 1048035
$123,331 04/03/2013 49 The University of Sydney 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Production of Off The Shelf T-cells Expressing a Non-MHC Restricted CD19 Specific Chimeric Antigen Receptor for use in a Phase I Study of
$47,500 04/03/2013 37 University of Sydney 2006
25 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
T-cell Therapy of Relapsed and Refractory Bcell Malignancies (UNI-T Study). Appl ID 1047454
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Investigating the mechanism of action of the cancer-associated enzyme telomerase using disease linked telomerase mutants. Appl ID 1048376
$24,972.75 04/03/2013 12 University of Sydney 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: The cost-effectiveness of adjuvant whole brain radiotherapy for melanoma brain metastases: a trial-based and modelled economic evaluation. Appl ID 1046923
$184,475 04/03/2013 36 University of Sydney 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: ICON8: An international multi-stage randomised phase III trial of dose-fractionated chemotherapy compared to standard three-weekly chemotherapy for women with newly diagnosed epithelial ovarian cancer. Appl ID 1044344
$257,241 04/03/2013 36 University of Sydney 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: The Use and Impact of High Cost Targeted Cancer Medicines: Theory and Reality. Appl ID 1050648
$133,002 04/03/2013 46 University of Sydney 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of New South Wales
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Testing of biomarkers of human papillomavirus on anal cytology in homosexual men to predict the presence of high-grade anal intraepithelial neoplasia and its progression and
$48,137.50 11/03/2013 32 Kensington 2232
26 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
persistence. Appl ID 1043299
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2009 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Translation of clinical and functional imaging data to brachytherapy treatment optimisation for prostate cancer ApplID: 628592
$86,395.83 27/03/2013 48 Parkville VIC 3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
2008 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Improving Outcomes for Women with Endometrial Cancer: Follow-up, survival and quality of life ApplID: 552468
$656,466.80 27/03/2013 60 Herston QLD 4006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Monash University
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Defining Epigenetic Changes in Prostate Cancer Stroma. Appl ID 1044458
$597,987 31/03/2013 36 Clayton 3800
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Garvan Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Characterising a new mode of regulation of the beta-catenin pathway in colorectal cancer. Appl ID 1049846.
$49,945.50 01/04/2013 24 Darlinghurst 2010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Adelaide
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Mechanism and targeting of castration-resistant prostate cancer. Appl ID 1043482.
$270,569 01/04/2013 36 Adelaide 5005
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Adelaide
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Targeting the androgen receptor in triple negative breast cancer. Appl ID 1043497.
$196,474.70 01/04/2013 36 Adelaide 5005
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Investigating the tumour-promoting phenotype of cancer-associated fibroblasts in serous
$24,640.25 01/04/2013 20 University of Sydney 2006
27 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
epithelial ovarian cancer. Appl ID 1050101
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland University of Technology
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Mirena ± Weight Loss to treat early Endometrial Cancer: (MAxWEL Trial). Appl ID 1044900
$600,000 01/04/2013 36 Kelvin Grove 4059
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Preferences for adjuvant chemotherapy in early non-small-cell lung cancer: what makes it worthwhile?: ApplID: 570905
$316,167.50 09/04/2013 59 University of Sydney 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Genomic determinants of chemosensitivity in ovarian cancer ApplID: 632595
$604,725 09/04/2013 39 University of Sydney 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Novel MicroRNA regulators in the Breast Cancer EMT ApplID: 628720
$281,620.90 18/04/2013 46 Parkville VIC 3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Adelaide
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: A pharmacodynamic study of the heat shock protein 90 (Hsp90) inhibitor, AUY922, in high-risk, localised prostate cancer. Appl ID 1050880.
$360,977 01/05/2013 59 Adelaide 5005
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Randomised phase III study of preop-chemoradiotherapy versus preop-chemotherapy for resectable gastric cancer: Appl ID: 570996
$595,301.66 07/05/2013 72 University of Sydney 2006
Cancer Australia
Improved Cancer Control
Anti-Cancer Council of Victoria
Capturing information on clinical stage, metastases at diagnosis and cancer recurrence employing IT solutions
$1,647,499 07/05/2013 42 Carlton, VIC 3053
Cancer Australia
Priority-driven Collaborative
University of Sydney
Priority Driven Collaborative Cancer Research Scheme $459,525 23/05/2013 59 University of Sydney 2006
28 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Cancer Research Scheme
(PDCCRS) 2008: The use and impact of cancer medicines in real world clinical practice: Evaluation in a cohort of elderly Australians. Appl ID: 568773
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Peter MacCallum Cancer Centre
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Randomised phase III trial to assess response adapted therapy using PET in newly diagnosed advanced Hodgkin Lymphoma. Appl ID: 628842
$124,666.67 23/05/2013 42 Peter MacCallum Cancer Centre 3002
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: RNA Loading of Tumour Associated Antigens and the Activation of Blood Dendritic Cells for Prostate Cancer Immunotherapy: Appl ID: 543713
$327,195 23/05/2013 74 University of Sydney 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Solving Unknown Primary cancER – SUPER. Appl ID 1048193.
$599,381 01/06/2013 61 Parkville 3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Accelerating First-Line Chemotherapy to Improve Cure Rates for Advanced Germ Cell Tumours: An Australian-Led, International Randomised Trial. Appl ID 1041733
$252,583.48 01/06/2013 50 University of Sydney 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Adding mitomycin C to intravesical BCG for high-risk, non-muscle-invasive bladder cancer: a randomised phase 3 trial. Appl ID 1041651
$457,143.17 01/06/2013 58 University of Sydney 2006
Cancer Australia
Priority-driven Collaborative Cancer Research
Queensland Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: Germline Copy Number Variants are
$24,420.50 01/06/2013 19 Herston 4028
29 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
SchemeGenetic Risk Factors for Familial Colorectal Cancer. Appl ID 1052035
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: RAD51 overexpression regulates pro-metastatic gene expression profiles of aggressive metastatic triple negative breast cancer. Appl ID 1050903
$24,764 01/06/2013 12 Herston 4028
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2012: A Phase II study to evaluate the safety and potential benefit of intraperitoneal (IP) bevacizumab to control symptomatic malignant ascites in patients with chemotherapy resistant ovarian cancers: REZOLVE (ANZGOG-1101). Appl ID 1050134
$277,958 28/06/2013 36 The University of Sydney, NSW 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: Identification of novel permissive mutations representing acquired vulnerabilities in lung cancer - CA-A1314/20 ApplID: 1070515
$50,000 04/02/2014 47 Herston, QLD 4028
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Walter and Eliza Hall Institute of Medical Research
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Regulating BAK and BAX conversion to death-inducing oligomers. App1069567 - CA-A1314/18
$27,500 15/02/2014 12 Parkville, VIC 3052
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Garvan Institute of Medical Research
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): From functional genomics to precision medicine: The therapeutic potential of targeting Rho/ROCK signalling in pancreatic cancer. App1065022 - CA-A1314/04
$599,997 17/02/2014 36 Darlinghurst, NSW 2010
30 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Princess Alexandra Hospital
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): A Randomised Trial of Postoperative Radiation Therapy Following Wide Excision of Neurotropic Melanoma of the Head and Neck. App1060687 Ref: CA1314-12
$335,000 20/02/2014 48 Woolloongabba, Qld 4102
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland Institute of Medical Research
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Understanding DNA integrity and telomerase in acute myeloid leukaemia stem cell function. App 1059292: CA-A1314/17
$25,000 27/02/2014 12 Herston, QLD 4028
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Ludwig Institute for Cancer Research
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Targeting the dimerisation arm of EGFR- biological effects and therapeutic implications. App 1063413: CA-A1314/23
$28,167.98 27/02/2014 24 Heidelberg, VIC 3084
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of NSW
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: A multicentre phase II randomised controlled trial of a parent/carer-targeted intervention to improve quality of life in families of young cancer survivors. ID 1065428. CA-A1314/02
$457,353 27/02/2014 48 Kensington 2052
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Maximising benefits and minimising harms in the BreastScreen program: a population health economics modelling approach. App 1066771: CA-A1314/06
$593,893 05/03/2014 48 Parkville, VIC 3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland University of Technology
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Mimicking the HSC niche and enabling HSC self-renewal in vitro.
$50,000 05/03/2014 24 Kelvin Grove, QLD 4059
31 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
App1060928: CA-A1314/21
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland University of Technology
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): miRSNPs as novel diagnostic and prognostic biomarkers for prostate cancer. App 1068321: CA-A1314/22
$50,000 05/03/2014 24 Kelvin Grove, QLD 4059
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: ECHO trial: Exercise during CHemotherapy for Ovarian cancer. ID 1063509
$300,000 18/03/2014 36 Sydney 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in men at higher genetic risk and controls – The IMPACT study. App 1059423: CA-A1314/01
$292,151 21/03/2014 44 Parkville, VIC 3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: Quantifying genetic risk in sarcoma and translation into health outcomes. ID1067094. CA-A1314/09
$597,793 21/03/2014 36 University of Melbourne 3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: Novel Therapies to Treat Brain Metastatic Breast Cancer. ID 1067045. CA-A1314/10
$398,447 28/03/2014 36 University of Melbourne 3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: ASCOLT: Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers. An International, Multi-centre, Double Blind, Randomised Trial. ID1068044. CA-A1314/08
$276,811.50 28/03/2014 36 Sydney 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Monash University 2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Nuclear receptors and their functions in breast cancer
$49,518.50 01/04/2014 24 Clayton, VIC 3800
32 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
stroma: identification of novel therapeutic targets. App 1058516: CA-A1314/19
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Investigation of molecular imaging and serum biomarkers to identify lung injury and enable individualised radiation therapy for lung cancers. App1060919
$498,012 01/04/2014 49 Parkville, VIC 3010
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Monash University
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): An inhalable dendrimer-based delivery platform for the targeted treatment of primary and secondary lung cancers. App 1070184: CA-A1314/11
$452,383 23/04/2014 36 Clayton, VIC 3800
Cancer Australia
Supporting People with Cancer Grant initiative
Paediatric Integrated Cancer Service
Supporting people with Cancer grant initiative $86,361.00 16/05/2014 25 Parkville VIC 3052
Cancer Australia
Supporting People with Cancer Grant initiative
The Prince Charles Hospital
Supporting people with Cancer grant initiative $88,000.00 16/05/2014 30 Brisbane, QLD 4032
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Phase 2 study of aromatase inhibitors in women with potentially hormone sensitive recurrent/metastatic gynaecological neoplasms: PARAGON. App 1063014: CA-A1314/69
$546,676 20/05/2014 36 The University of Sydney, NSW 2006
Cancer Australia
Jeannie Ferris Cancer Australia Recognition Award 2014
Various
To recognise outstanding contribution in gynaecological cancer through the Jeannie Ferris Cancer Australia Recognition Award
$4,000 26/05/2014 NA
Cancer Australia
Priority-driven Collaborative Cancer Research
University of Melbourne
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): A randomised trial of
$320,000 01/06/2014 43 Parkville, VIC 3010
33 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Scheme
stereotactic radiotherapy versus conventional radiotherapy for stage I non-small cell lung cancer. App1060822 Ref: CA-1314/14
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Arts out West Inc
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/04
$2,200 05/06/2014 3 Bathurst, NSW 2795
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Cancer Council NT Inc
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/06
$4,400 05/06/2014 3 Casuarina, NT 810
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Central and North West Queensland Medicare Local
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/07
$3,993 05/06/2014 3 Normanton QLD 4890
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Country Health SA Local Health Network Inc
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/08
$3,000 05/06/2014 3
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Hume Regional Integrated Cancer Service
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/09
$3,410 05/06/2014 3 Shepparton, VIC 3630
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Institute for Urban Indigenous Health
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/11
$1,650 05/06/2014 3
Cancer Australia
Aboriginal and Torres Strait Islander Well
Jacaranda Community Centre
To use Cancer Australia’s Community Education Resources to hold a Well
$1,870 05/06/2014 3 Cloverdale QLD 6985
34 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Women’s Workshop Grant Initiative
Women Workshop. Ref: CA-G1415/13
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Kurranulla Aboriginal Corporation
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/14
$2,200 05/06/2014 3 Jannali NSW 2226
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Malabam Health Board Aboriginal Corporation
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/16
$3,696 05/06/2014 3 Maingride NT 822
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Metro South Addictions & Mental Health Service
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/17
$2,750 05/06/2014 3 Upper Mount Gravatt QLD 4122
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
MiiMi Aboriginal Corporation
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/18
$2,750 05/06/2014 3 Bowraville NSW 2449
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Pika Wiya Health Service
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/20
$3,000 05/06/2014 3 Port Augusta SA 5700
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Walgett AMS
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/21
$4,400 05/06/2014 3 Walgett NSW 2832
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop
Went West Limited
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/22
$2,200 05/06/2014 3 Blacktown NSW 2148
35 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Grant Initiative
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Menzies School of Health Research
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/12
$4,000 06/06/2014 3 Brisbane QLD 4000
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Liverpool Women’s Health Centre
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/15
$1,430 06/06/2014 3 Liverpool NSW 1871
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Oak Valley Maralinga Incorporated
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/19
$2,750 06/06/2014 3 Ceduna SA 5690
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Winanga-Li
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/23
$2,860 06/06/2014 3 Gunnedah NSW 2380
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of NSW
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: MRP4 and MRP3 transporters: potential new targets in ovarian cancer. ID1067110. CA-A1314/71
$589,989 10/06/2014 36 Sydney 2052
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: REZOLVE: A Phase II study to evaluate the safety and potential palliative benefit of intraperitoneal bevacizumab in patients with symptomatic ascites due to advanced chemotherapy resistant gynaecological cancers. ID1067589. CA-A1314/70
$119,280 10/06/2014 36 Sydney 2006
Cancer Australia
Supporting People with
Cancer Council South Australia
Supporting people with Cancer grant initiative $85,800.00 10/06/2014 31 Eastwood, SA 5063
36 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Cancer Grant initiative
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
La Trobe University
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): A Randomised phase II trial of Adaptive Image guided standard or Dose Escalated Radiotherapy in the treatment of transitional cell carcinoma of the Bladder (RAIDER-B). App1063072 Ref: CA1314-03
$280,000 16/06/2014 54 Melbourne, VIC 3086
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Hitting the Target: Real-Time Prostate Cancer Radiotherapy. App1064731 Ref: CA1314-05
$171,854 16/06/2014 36 Sydney, NSW 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2013: High risk genes for childhood cancer: using massively parallel sequencing to identify cancer susceptibility ID1070106
$200,000.00 17/06/2014 30 Parkville 3010
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Inala Indigenous Health
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/10
$2,255 17/06/2014 3 Inala, QLD 4077
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Maari Ma Health Aboriginal Corporation
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/05
$2,750 25/06/2014 3 Broken Hill, NSW 2880
Cancer Australia Data
The Flinders University of South Australia
To collect data in order to assess the Testicular Cancer Data Set Specification
$16,510 26/06/2014 8 Bedford Park, SA 5042
Cancer Australia Data
Adventist HealthCare Limited
To collect data in order to assess the Testicular Cancer Data Set Specification
$22,000 27/06/2014 8 Wahroonga, NSW 2076
Cancer Australia
Data Peter MacCallum Cancer Institute T/A Peter
To collect data in order to assess the Testicular Cancer Data Set Specification
$20,000 27/06/2014 8 Melbourne, VIC 8006
37 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
MacCallum Cancer Centre
Cancer Australia
Improving evidence base
Lung Cancer Foundation Australia
Review and update the “Lung Cancer – understanding, managing, living” DVD Ref: CA-G1415/24
$16,500.00 30/06/2014 4 Milton, QLD 4064
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Walter and Eliza Hall Institute of Medical Research
2013 Priority-driven Collaborative Cancer Research Scheme (PdCCRS): Identification of the critical p53 tumor suppression mechanisms in vivo. App 1067571 - CA-A1314/15
$27,361.68 14/07/2014 12 Parkville, VIC 3052
Cancer Australia
Ralph Lauren Pink Pony seeding grant
Cancer Council Tasmania
Ralph Lauren Pink Pony seeding grants: Cancer Council Tasmania will deliver free Pilates classes to women in rural and remote areas. The classes are specifically designed for women with breast cancer to increase core and general strength, decrease fatigue, improve sleep and overall wellbeing and provide opportunity for social interaction. The classes are currently run from a metropolitan centre and will be extended to women in rural and remote areas via video conferencing facilities. Ref: CA-G1415/31
$9,460 16/07/2014 12 Hobart, TAS 7000
Cancer Australia
Ralph Lauren Pink Pony seeding grant
Support4Cancer The Support4Cancer project recognises that male partners caring for women with breast cancer have their own unmet supportive care needs which can have a detrimental impact on their wellbeing and also affect their ability to provide support for their wives during the breast cancer journey. The project will deliver two region-wide community forums seeking to address some of these unmet supportive care needs, which will be of
$$4,900 24/07/2014 12 Ballarat, VIC 3350
38 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
benefit to male partners and women affected by breast cancer.
Cancer Australia
Supporting Women in Rural Areas Diagnosed with Breast Cancer
Breast Cancer Network Australia
My Journey Kit, Hope and Hurdles and promotion of Stay in Touch Ref: CA-G1415/35
$2,619,100 01/08/2014 36 Camberwell, VIC 3122
Cancer Australia
Ralph Lauren Pink Pony seeding grant
Dandenong Ranges Music Council Incorporated
Ralp Lauren Pink Pony seeding grant - outreach program for women living with breast cancer. Ref: CA-G1415/36
$8,861.50 15/08/2014 12 Upwey, VIC 3158
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Tharawral Aboriginal Corporation
To use Cancer Australia’s Community Education Resources to hold a Well Women Workshop. Ref: CA-G1415/34
$1,100 31/08/2014 3 Campbelltown, NSW 2560
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS):Pain Free TRUS B: A placebo-controlled, randomised trial of methoxyflurane to reduce the discomfort of prostate biopsy. App.1079794: CA-G1415/40
$297,525.00 27/11/2014 36 University of Sydney 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Reducing Thoracic Imaging Dose and Improving Image Quality in Radiotherapy Treatments. App.1084566: CA-G1415/41
$458,459.00 27/11/2014 36 University of Sydney 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS):Real-time Six Degree of Freedom Tumour Motion Management in Cancer Radiotherapy. App.1085360: CA-G1415/42
$441,385.00 27/11/2014 45 University of Sydney 2006
Cancer Australia
Priority-driven Collaborative Cancer Research
University of Sydney
2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Molecular Functions of the
$19,557.00 27/11/2014 24 University of Sydney 2006
39 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Scheme
Iron Regulated Metastasis Suppressor, NDRG1 and its Potential as a Molecular Target. App.1086449: CA-G1415/43
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
The Council of the Queensland Institute of Medical Research
2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Targeting suppressive TGF-βR and A2AR pathways in natural killer (NK) cells: Enhancing the anti-metastatic response against breast cancer progression. App.1082709: CA-G1415/44
$50,000.00 27/11/2014 12 Herston 4028
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
The Council of the Queensland Institute of Medical Research
2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Eph Receptor Tyrosine Kinases as Targets for Therapy in Paediatric Medulloblastoma. App.1080218: CA-G1415/45
$66,573.00 27/11/2014 24 Herston 4028
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland University of Technology
2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Targeting neuropilin-1 to inhibit prostate cancer metastasis and therapy resistance. App.1088878: CA-G1415/46
$63,870.00 27/11/2014 24 Kelvin Grove 4059
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Phase III trial of Concurrent & Adjuvant Temozolomide chemotherapy in non-1p/19q deleted anaplastic glioma. App.1078665: CA-G1415/39
$190,213.00 28/02/2015 36 University of Sydney 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): SCOT - Short Course Oncology Therapy - A study of adjuvant chemotherapy in colorectal cancer. App. 1086013: CA-G1415/49
$90,253 02/04/2015 36 University of Sydney 2006
Cancer Australia
Priority-driven Collaborative Cancer Research
University of Sydney
2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): ANZMTG 01.07 Whole Brain
$335,963 13/04/2015 36 University of Sydney 2006
40 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Scheme
Radiotherapy (WBRT) following local treatment of intracranial metastases of melanoma – a randomised phase III trial. App. 1084046: CA-G1415/50
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): ANZMTG 01.12 RADICAL – RADiotherapy (RT) or Imiquimod (ImiQ) in Complex lentigo mALigna (LM). App. 1083221: CA-G1415/51
$600,000 13/04/2015 36 University of Sydney 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland University of Technology
2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Identification of HNF1B downstream targets as novel cancer therapeutic targets and biomarkers. App. 1086830: CA-G1415/52
$100,000 13/04/2015 30 Kelvin Grove 4059
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Adelaide
2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Molecular hallmarks of heat shock protein 90 inhibition in prostate cancer. App. 1085471: CA-G1415/53
$553,483 24/04/2015 36 Adelaide 5005
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Australian National University
2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Novel combination therapies targeting the ribosome to treat prostate cancer (PC). App. 1084546: CA-G1415/54
$599,492 28/04/2015 36 Acton 200
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Sydney
2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS):SPARK: Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction Monitoring. App. 1081534: CA-G1415/55
$387,599 29/04/2015 36 The University of Sydney 2006
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Queensland University of Technology
2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Evaluating combination therapies in FGFR2mutant
$600,000 01/05/2015 36 Kelvin Grove 4059
41 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
EC cell lines and patient-derived xenograft models.. App. 1087165: CA-G1415/56
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
The University of Western Australia
2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Mammographic density as a predictor of breast cancer risk and mortality in Western Australian Aboriginal women. App. 1085750: CA-G1415/59
$137,651 04/05/2015 32 Crawley 6009
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Melbourne
2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): Investigating the safety and efficacy, quality of life, cost-efficiency and immune potential of high precision lung radiotherapy. App. 1082399: CA-G1415/63
$439,418 03/06/2015 36 Parkville 3010
Cancer Australia
Supporting People with Cancer Grant initiative
Lung Foundation Australia
Supporting people with Cancer grant initiative: Nurse-led lung cancer support service Ref: CA-G1516/02
$132,000 04/06/2015 36 Milton 4064
Cancer Australia
Supporting People with Cancer Grant initiative
Rare Cancers Australia Ltd
Supporting people with Cancer grant initiative: Rare Cancers Patient Support Program. Ref: CA-G1516/01
$132,000 04/06/2015 36 Bowral 2576
Cancer Australia
Supporting People with Cancer Grant initiative
Cancer Council NSW
Supporting people with Cancer grant initiative: Develop and implement online, audio-visual webinar information sessions in Mandarin and Cantonese to address the unmet needs of people in the Chinese community who are affected by cancer; and compile existing supportive care services and resources available to the Chinese community. Ref: CA-G1516/07
$122,100 09/06/2015 36 Woolloomooloo 2011
Cancer Australia
Supporting People with Cancer Grant initiative
University of Melbourne
Supporting people with Cancer grant initiative: Engage the Vietnamese community to develop culturally-specific resources and a supporting community
$120,000 12/06/2015 36 Parkville 3010
42 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
engagement campaign to raise awareness about cancer symptoms and promote earlier presentation to healthcare in the Vietnamese community. Ref: CA-G1516/08
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Queensland
2014 Priority Driven Collaborative Cancer Research Scheme (PDCCRS): The feMMe trial. App. 1078121: CA-G1415/60
$540,000 16/06/2015 36 St Lucia 4072
Cancer Australia
2015-2016 Ralph Lauren Pink Pony Seeding Grant
Cancer Council Northern Territory
2015-2016 Ralph Lauren Pink Pony seeding grant: Yoga for Life - To support community based initiatives that aim to improve access to information, support and services for women with breast cancer in communities in Australia. Ref: CA-G1415/65
$11,000 24/06/2015 12 Wanguri 810
Cancer Australia
2015-2016 Ralph Lauren Pink Pony Seeding Grant
Ishar Multicultural Women's Health Centre
2015-2016 Ralph Lauren Pink Pony seeding grant: Pink Ladies - To establish a support program for women form culturally and linguistically diverse backgrounds with breast cancer. Ref: CA-G1415/64
$11,000 25/06/2015 12 Mirrabooka 6061
Cancer Australia
2015-2016 Ralph Lauren Pink Pony Seeding Grant
Boronia Multicultural Services
2015-2016 Ralph Lauren Pink Pony seeding grant: Swasthi (Wellbeing) - To train community volunteers to support South-Asian women with breast cancer. Ref: CA-G1415/66
$11,000 26/06/2015 12 Toongabbie 2146
Cancer Australia
Ralph Lauren Pink Pony seeding grant
Anti-Cancer Council TA Cancer Council Victoria
Ralph Lauren Pink Pony seeding grants: Anti-Cancer Council Victoria will deliver an online interactive resource that links women seeking face-to-face support to Cancer Council Victoria support groups in their local area. The support groups offer people with cancer a chance to meet regularly and talk about common issues and connect with others who've been through
$8,861.50 30/06/2015 12 Melbourne, VIC 3004
43 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
a similar cancer journey. The online resource will enable women to identify groups that best meet their personal needs by enabling them to search for support groups for women with a particular stage of cancer, identify the distance they are able to travel, and whether the group welcomes carers of family members. Ref: CA-G1415/32
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Western Australia
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2015: Identification of the molecular networks that drive mesothelioma invasion: ID1107743. Ref: CA-G1516/10
$38,676 27/01/2016 12 Crawley 6009
Cancer Australia
Supporting People with Cancer Grant initiative round 8
Lung Foundation Australia
This project will develop and deliver a set of patient-centred evidence based webinars to improve health literacy and assist patients to more effective self-manage their condition and connect them with the services they need.
$132,000 28/01/2016 36 Milton 4064
Cancer Australia
Supporting People with Cancer Grant initiative round 8
Menzies School of Health Research
This project will develop a knowledge transfer and implementation framework for supportive care needs for Indigenous Australian along the cancer continuum.
$131,472 29/01/2016 36 Tiwi 801
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of South Australia
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2015: Targeting the IL-3/IL-3 receptor axis to prevent breast cancer progression: ID1105828. Ref: CA-G1516/11
$290,983 02/02/2016 36 Adelaide 5001
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
University of Technology Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2015: The role of long-non coding RNAs in Acute Myeloid Leukaemia: ID1100978. Ref: CA-G1516/13
$49,605 04/02/2016 12 Ultimo 2007
Cancer Supporting Brain Tumour Provide a core set of $85,000 05/02/2016 36 Pearce 260744 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
AustraliaPeople with Cancer Grant initiative round 8
Alliance Australia
information suitable for brain tumour patients, their carers and family members to improve health and quality of life outcomes for people affected by brain tumours.
Cancer Australia
Priority-driven Collaborative Cancer Research Scheme
Garvan Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2015: From mice to men: biomarker-driven classification of pancreatic cancer to define the gemcitabine/ nab-paclitaxel-responsive molecular subtype: ID1100722. Ref: CA-G1516/12
$600,000 15/02/2016 36 Darlinghurst 2010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Developing a Patient-Reported Symptom Index for Non-muscle Invasive Bladder Cancer: ID1103036 Ref: CA-G1516/19
$233,159 18/02/2016 36 The University of Sydney 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Developing a rapid and quantitative telomere length test to measure chemotherapeutic response to telomerase inhibition: ID1099299 Ref: CA-G1516/20
$48,495 18/02/2016 12 The University of Sydney 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Improving the cure rates of childhood brain cancer ID1101390 Ref: CA-G1516/22
$64,564 18/02/2016 24 The University of Sydney 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Generation and use of novel model systems to study steroid hormone action in the breast: ID1098796 Ref: CA-G1516/23
$98,661 18/02/2016 24 The University of Sydney 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Phase II randomised placebo-controlled, double blind, multisite study of acetazolamide versus placebo for management of cerebral oedema in recurrent and/or progressive HGG requiring treatment with dexamethasone – The ACED trial: ID1098932 Ref: CA-G1516/24
$524,365 29/02/2016 36 The University of Sydney 2006
Cancer Priority Driven University of Adjuvant chemotherapy with $497,544 29/02/2016 36 The University of 200645 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
AustraliaCollaborative Cancer Research Scheme
Sydney
gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 Trial): ID1100306 Ref: CA-G1516/25
Sydney
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Queensland
Long-term follow-up of the Laparoscopic Approach to Carcinoma of the Endometrium (LACE) Trial – survival outcomes: ID1098905 Ref: CA-G1516/28
$380,674 07/03/2016 24 St Lucia 4072
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Melbourne Health
CaPP3: a randomized double blind dose inferiority trial of aspirin in Lynch Syndrome: ID1103035 Ref: CA-G1516/29
$290,340.50 11/03/2016 36 Parkville 3056
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Garvan Institute of Medical Research
A novel approach to overcome treatment-resistance in breast cancer: ID1107170 Ref: CA-G1516/30
$415,770 11/03/2016 36 Darlinghurst 2010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Translating Evidence into Practice: Optimising and Facilitating Prevention and Screening in Women with a Strong Family History of Breast Cancer: ID1100868 Ref: CA-G1516/31
$258,345 15/03/2016 36 Parkville 3010
Cancer Australia
Supporting People with Cancer Grant initiative
Peter MacCallum Cancer Institute T/A Peter MacCallum Cancer Centre
Improving information provision and support for underserved cancer survivors. Ref: CA-G1516/36
$132,000 30/03/2016 25 Melbourne 3000
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Curtin University of Technology
Confidence to Care: A multi-state randomised controlled trial of structured nurse-led home-based support and education for carers of people with high grade glioma.: ID1105307 Ref: CA-G1516/33
$535,789 06/04/2016 36 Perth 6102
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
ICON9: A phase 3 randomised trial of cediranib and olaparib maintenance in patients with relapsed platinum sensitive ovarian
$600,000 06/04/2016 36 The University of Sydney
2006
46 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
cancer: ID1100619 Ref: CA-G1516/34
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
The PEARL trial: Palliative care Early in Advanced Lung cancers: ID1101882 Ref: CA-G1516/37
$598,099 18/04/2016 36 The University of Sydney 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Melbourne
Resolution of the missing heritability of breast cancer: ID1107870 Ref: CA-G1516/38
$299,822 03/05/2016 36 Parkville 3010
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
La Trobe University
A multistage multi centre international randomised trial of Conventional care Or Radioablation(stereotactic body radiotherapy) for Extra-cranial oligometastatic disease in lung, breast and prostate cancer (CORE): ID1104569 Ref: CA-G1516/32
$430,563 16/05/2016 36 Bundoora 3086
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2015: Counting the Cost of Curing Childhood ALL by Transplantation. ID1102140. CA-G1516/39
$350,000 30/05/2016 36 Sydney 2006
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Bloomhill Cancer Care
Support community-based initiatives that aim to improve access to information, support and services for women with breast cancer in Australia: Bloomfield Lymphodema Information, Support and Services (BLISS) project. Ref: CA-G1516/42
$6,200.28 15/06/2016 12 Buderim 4556
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
CanRevive Inc.
Support community-based initiatives that aim to improve access to information, support and services for women with breast cancer in Australia: Information for Chinese women affected by Breast Cancer project. Ref: CA-G1516/43
$11,000.00 15/06/2016 12 Sydney 2000
Cancer Australia
Aboriginal and Torres Strait Islander Well
Cancer Council New South Wales
Support community-based initiatives that aim to improve access to
$11,000.00 15/06/2016 12 Woolloomooloo 2011
47 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Women’s Workshop Grant Initiative
information, support and services for women with breast cancer in Australia: Yarning about cancer - Supporting indigenous Breast Cancer Peer Support Group leaders project. Ref: CA-G1516/44
Cancer Australia
Aboriginal and Torres Strait Islander Well Women’s Workshop Grant Initiative
Westmead Breast Cancer Institute
Supporting Indigenous women with breast cancer - Delivering breast cancer education workshops to Aboriginal and Torres Strait Islander health workers project. Ref: CA-G1516/41
$10,000.00 17/06/2016 12 North Sydney 2060
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Technology, Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Randomised double blind placebo controlled phase III trial of oral melatonin for the prevention of delirium in hospital in people with advanced cancer: ID1127727. Ref: CA-G1516/54
$599,820.00 03/03/2017 36 Ultimo 2007
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Walter and Eliza Hall Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Development of a Clinico-Molecular Colon Cancer Nomogram for personalisation of adjuvant chemotherapy in the Australian population: ID1120882. Ref: CA-G1516/56
$594,254.00 08/03/2017 36 Parkville 3052
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Computed tomography (CT) and positron emission tomography (PET)/CT surveillance imaging in asymptomatic Stage III melanoma patients - a prospective cohort study of clinical benefit and economic implications: ID1129568. Ref: CA-G1516/57
$481,698.00 08/03/2017 36 The University of Sydney 2006
48 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Lowy Cancer Research Centre, University of NSW
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Reversing glucocorticoid resistance in paediatric acute lymphoblastic leukaemia - a novel epigenetic mechanism linked to lymphocyte-specific chromatin conformation: ID1129129. Ref: CA-G1516/52
$296,428.50 10/03/2017 36 Kensington 2052
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: ASCOLT: Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers. An International, Multi-centre, Double Blind, Randomised Trial: ID1122632 Ref: CA-G1516/51
$213,459.53 17/03/2017 36 The University of Sydney 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Lowy Cancer Research Centre, University of NSW
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Targeting FACT to inhibit MYCN-driven transcription in neuroblastoma: ID1123235 Ref: CA-G1516/53
$496,055.50 17/03/2017 36 Kensington 2052
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Council of the Queensland Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Improving Natural Killer cell responses to immunotherapy in haematological cancers: ID1122183. Ref: CA-G1516/59
$49,669.50 17/03/2017 12 Herston 4006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Sydney Children's Hospital, University of NSW
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Synthetic retinoid therapy for Diffuse Intrinsic Pontine Gliomas: ID1126580. Ref: CA-G1516/66
$200,000.00 23/03/2017 36 Kensington 2052
Cancer Australia
Supporting People with Cancer Grant initiative
University of Melbourne Centre for Cancer Research
Supporting people with cancer Grant initiative 2017, Round 9: PanSupport- an experience based co-design, supportive care app with and for people affected by pancreatic cancer. Ref: CA-G1617/81
$115,000.00 27/03/2017 36 Parkville 3052
49 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Cancer Australia
Supporting People with Cancer Grant initiative
Cancer Council Australia
Supporting people with cancer Grant initiative 2017, Round 9: Production of psychosocial and information resources for Australians with less common cancers. Ref: CA-G1617/82
$128,405.00 27/03/2017 36 Sydney 2000
Cancer Australia
Supporting People with Cancer Grant initiative
North Metropolitan Health Service
Supporting people with cancer Grant initiative 2017: Adolescent and Young Adult (AYA) Life Now Group Exercise Program. Ref: CA-G1617/80
$112,462.00 30/03/2017 36 Nedlands 6009
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Walter & Eliza Hall Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Transcriptional control of IL-17 producing T cells in gastrointestinal cancers: ID1123388. Ref: CA-G1516/76
$98,222.00 31/03/2017 24 Parkville 3052
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Prince of Wales Hospital, University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Phase III Intergroup Study of Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy with Adjuvant PCV Chemotherapy in Patients with 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma: the CODEL trial: ID1130584. Ref: CA-G1516/67
$221,534.04 04/04/2017 36 The University of Sydney 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Lowy Cancer Research Centre, University of NSW
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Reprogramming the Tumour Microenvironment with the use of Nanomedicines for the Treatment of Pancreatic Cancer: ID1126736. Ref: CA-G1516/69
$247,983.25 04/04/2017 36 Sydney 2052
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Council of the Queensland Institute of Medical Research
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Dnmt3a loss contributes to disease progression in myeloproliferative
$100,000.00 04/04/2017 24 Herston 4006
50 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
neoplasm: ID1124096. Ref: CA-G1516/77
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Macquarie University
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Differential effects of MAPK inhibition on immune activity determine melanoma response: ID1123911. Ref: CA-G1516/78
$2,078.50 04/04/2017 24 Macquarie University 2109
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Phase II clinical trial of the PARP inhibitor, olaparib, in HR- deficient advanced breast and ovarian cancer in women without inherited BRCA1 or BRCA2 mutations: ID1128740. Ref: CA-G1516/71
$300,000.00 10/04/2017 36 The University of Sydney 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Australian National University
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: AUTO-CHECK study: Molecular determinants of autoimmunity and immune related adverse events in advanced cancer patients treated with immune checkpoint inhibitors: ID1130330. Ref: CA-G1516/74
$574,009.00 10/04/2017 36 Acton 2601
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: High Precision Radiotherapy: Dual Cardiac and Respiratory Motion Management: ID1123068. Ref: CA-G1516/55
$597,325.50 28/04/2017 36 The University of Sydney 2006
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: The SPAR Trial: a randomised placebo-controlled phase 2 trial of simvastatin with preoperative chemoradiation for rectal cancer. ID1125958. Ref: CA-G1617/85
$148,857.00 02/06/2017 36 The University of Sydney 2006
51 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Newcastle
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Assessing Behaviour Change Techniques for Indigenous Pregnant Smokers attending Aboriginal Medical Services - a nested study in a cluster Randomised Controlled Trial. ID 1125695. CA-G1516/75.
$50,000 08/06/2017 12 Callaghan 2308
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of NSW
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Therapeutically targeting a solute carrier transporter in the stroma of pancreatic cancer. ID1126738. Ref: CA-G1617/84
$511,966.00 13/06/2017 36 Kensington 2052
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
Cancer Council New South Wales
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Hide and seek with hereditary cancer: Improving detection of colorectal cancer patients with a high risk of Lynch syndrome. ID1123924 CA-G1516/70.
$579,140 13/06/2017 36 Woolloomooloo 2011
Cancer Australia
Supporting People with Cancer Grant initiative
Australia New Zealand Gynaecological Oncology Group
Supporting People with Cancer Grant Initiative, 2017, Round 9: Survivors Teaching Students: Saving Women's lives. Ref: CA-G1617/87
$132,000.00 15/06/2017 36 Camperdown 2050
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of NSW
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Improving outcomes for high risk ALL treated with new therapies and transplant. ID1128727. Ref: CA-G1617/86
$600,000.00 16/06/2017 36 Kensington 2052
Cancer Australia
Priority Driven Collaborative Cancer Research Scheme
University of Technology Sydney
Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: A phase III wait-listed RCT of a novel targeted inter-professional clinical education intervention to improve cancer patients’ reported pain outcomes. ID1127011 Ref: CA-G1617/83
$342,483.00 19/06/2017 36 Ultimo 2007
Cancer Priority Driven University of Priority Driven Collaborative $242,789 21/06/2017 24 Crawley 600952 of 54
Agency Program Title
Program Component
(if applicable)
Recipient Purpose Value Date of Effect
Grant Term
(months)
Grant Funding Location Postcode
AustraliaCollaborative Cancer Research Scheme
Western Australia
Cancer Research Scheme (PDCCRS) 2016: FGF-Receptor Antagonist in Mesothelioma (FRAME) Study: A Phase II Clinical Trial. ID1121215. CA-G1516/68
Cancer Australia
Supporting People with Cancer Grant initiative
Cancer Council Victoria
Supporting People with Cancer Grant Initiative, 2017, Round 9: Keeping Things on Track. Ref: CA-G1617/88
$131,230.00 21/06/2017 36 Melbourne 3004
Cancer Australia
Supporting People with Cancer Grant initiative
Breast Cancer Network Australia
Supporting people with Cancer grant initiative: Develop and disseminate evidence-based, culturally appropriate and in-language resources for Greek and Chinese women affected by secondary breast cancer. Ref: CA-G1516/03
$131,552.30 30/06/2105 36 Camberwell 3124
Cancer Australia
Supporting People with Cancer Grant initiative
Cancer Council Australia
Supporting people with Cancer grant initiative: Develop a culturally-specific and accessible web-based resource to meet the identified needs of specific CALD communities affected by cancer. Ref: CA-G1516/04
$132,000 30/06/2105 36 Sydney 2000
Cancer Australia
Supporting People with Cancer Grant initiative
Cancer Council QLD
Supporting people with Cancer grant initiative: Design and deliver evidence-based cancer control courses for Aboriginal and Torres Strait Islander health workers and build local cancer support networks for Aboriginal and Torres Strait Islander people affected by cancer living in regional and rural Queensland. Ref: CA-G1516/05
$132,000 30/06/2105 36 Fortitude Valley 4006
Cancer Australia
Supporting People with Cancer Grant initiative
Aboriginal Health and Medical Research Council NSW
Supporting people with Cancer grant initiative: : Develop locally led Aboriginal cancer networks to support local communities affected by cancer. Ref: CA-G1516/06
$132,000 30/06/2105 36 Surry Hills 2010
53 of 54
54 of 54